Revvity, Inc. (NYSE:RVTY) Shares Sold by Mutual of America Capital Management LLC

Mutual of America Capital Management LLC lessened its holdings in shares of Revvity, Inc. (NYSE:RVTY) by 3.8% during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 15,544 shares of the company’s stock after selling 618 shares during the period. Mutual of America Capital Management LLC’s holdings in Revvity were worth $1,630,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Czech National Bank boosted its position in Revvity by 0.5% during the 1st quarter. Czech National Bank now owns 21,713 shares of the company’s stock worth $2,280,000 after acquiring an additional 99 shares during the period. Garrison Asset Management LLC lifted its holdings in Revvity by 0.5% in the second quarter. Garrison Asset Management LLC now owns 21,328 shares of the company’s stock worth $2,236,000 after purchasing an additional 103 shares during the period. TriaGen Wealth Management LLC grew its position in Revvity by 2.3% in the 2nd quarter. TriaGen Wealth Management LLC now owns 4,767 shares of the company’s stock valued at $500,000 after buying an additional 107 shares in the last quarter. Guinness Asset Management LTD grew its position in Revvity by 3.3% in the 2nd quarter. Guinness Asset Management LTD now owns 3,587 shares of the company’s stock valued at $376,000 after buying an additional 116 shares in the last quarter. Finally, Inspire Investing LLC increased its stake in Revvity by 2.9% during the 1st quarter. Inspire Investing LLC now owns 4,190 shares of the company’s stock valued at $440,000 after buying an additional 117 shares during the period. 86.65% of the stock is owned by institutional investors.

Insider Buying and Selling at Revvity

In related news, insider Joel S. Goldberg sold 3,500 shares of the stock in a transaction on Wednesday, August 7th. The stock was sold at an average price of $117.86, for a total transaction of $412,510.00. Following the completion of the sale, the insider now directly owns 33,400 shares in the company, valued at $3,936,524. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. Company insiders own 0.60% of the company’s stock.

Analyst Upgrades and Downgrades

RVTY has been the subject of several recent analyst reports. Barclays increased their price objective on shares of Revvity from $115.00 to $125.00 and gave the company an “equal weight” rating in a report on Tuesday, July 30th. JPMorgan Chase & Co. lifted their price target on Revvity from $105.00 to $120.00 and gave the company a “neutral” rating in a research report on Tuesday, July 30th. TD Cowen upped their price objective on Revvity from $130.00 to $141.00 and gave the company a “buy” rating in a report on Tuesday, July 30th. Leerink Partnrs raised Revvity to a “strong-buy” rating in a research note on Monday, July 8th. Finally, Citigroup boosted their price target on shares of Revvity from $135.00 to $145.00 and gave the stock a “buy” rating in a research report on Tuesday, July 30th. Eight investment analysts have rated the stock with a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $126.00.

Revvity Stock Performance

Shares of Revvity stock opened at $126.34 on Friday. Revvity, Inc. has a 12 month low of $79.50 and a 12 month high of $128.15. The company has a quick ratio of 1.98, a current ratio of 2.27 and a debt-to-equity ratio of 0.40. The stock has a market cap of $15.59 billion, a PE ratio of 104.41, a price-to-earnings-growth ratio of 2.90 and a beta of 1.05. The business has a fifty day simple moving average of $119.75 and a 200-day simple moving average of $110.91.

Revvity (NYSE:RVTY) last announced its quarterly earnings data on Monday, July 29th. The company reported $1.22 EPS for the quarter, topping analysts’ consensus estimates of $1.12 by $0.10. The firm had revenue of $691.70 million during the quarter, compared to analyst estimates of $690.33 million. Revvity had a return on equity of 7.34% and a net margin of 6.26%. The business’s quarterly revenue was down 2.5% compared to the same quarter last year. During the same period last year, the company posted $1.21 EPS. On average, sell-side analysts anticipate that Revvity, Inc. will post 4.75 EPS for the current fiscal year.

Revvity Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 8th. Shareholders of record on Friday, October 18th will be given a $0.07 dividend. The ex-dividend date is Friday, October 18th. This represents a $0.28 dividend on an annualized basis and a yield of 0.22%. Revvity’s payout ratio is 23.14%.

About Revvity

Revvity, Inc provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally. The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services. Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.